Validation of break-apart and fusion MYC probes using a digital fluorescence in situhybridization capture and imaging system
Michael Liew(ARUP Laboratories (United States)), Mohamed E. Salama(The University of Texas at San Antonio Health Science Center), Rodney R. Miles(Inserm), Parker W. Clement(University of Utah), Leslie R. Rowe(ARUP Laboratories (United States))
Cited by 18
Related Papers
MYC Drives Progression of Small Cell Lung Cancer to a Variant Neuroendocrine Subtype with Vulnerability to Aurora Kinase Inhibition
|Cancer Cell|2017|619
Spectrum of Epithelial Neoplasms in End-Stage Renal Disease
|The American Journal of Surgical Pathology|2006|484
A genetic mechanism for Tibetan high-altitude adaptation
|Nature Genetics|2014|441
Rituximab for High-Risk, Mature B-Cell Non-Hodgkin’s Lymphoma in Children
|New England Journal of Medicine|2020|308